Close Menu

Amgen

The companies plan to codevelop Adaptive's ClonoSeq assay to measure minimal residual disease in ALL. 

The company plans to use the funds to build up a Dublin-based genomic research and development program based on the model of Iceland's Decode Genetics.

The deal follows a June agreement under which Exosome is developing an exosomal RNA sequencing platform with Takeda.

A study in NEJM found that rare, loss-of-function mutations in the asialoglycoprotein receptor gene coincide with lower non-HDL levels and decreased coronary artery disease risk.

DeCode Genetics' Kari Stefansson and his colleagues uncovered a dozen genetic variants that influence blood lipids, and explored links to coronary artery disease.

Amgen has posted three of its failed efforts to confirm findings from high-profile journal articles online to encourage others to do likewise.

The tests analyze tumor samples for mutations oncogenes including KRAS and NRAS in order to help guide treatment decisions for patients with metastatic colorectal cancer.

DeCode's Kari Stefansson and his colleagues report that creativity and conditions like schizophrenia and bipolar disorder share a genetic source.

Drug companies are rushing toward genomic databases to inform their searches for new drugs, Reuters reports.

Four related studies out today describe preliminary findings from whole-genome sequences for more than 2,600 Icelanders, offering a glimpse at rarer forms of genetic variation, including loss-of-function mutations affecting both alleles of a gene.

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.